David O. Cosgrove

23.9k total citations · 3 hit papers
193 papers, 10.0k citations indexed

About

David O. Cosgrove is a scholar working on Biomedical Engineering, Radiology, Nuclear Medicine and Imaging and Hepatology. According to data from OpenAlex, David O. Cosgrove has authored 193 papers receiving a total of 10.0k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Biomedical Engineering, 63 papers in Radiology, Nuclear Medicine and Imaging and 45 papers in Hepatology. Recurrent topics in David O. Cosgrove's work include Ultrasound and Hyperthermia Applications (67 papers), Hepatocellular Carcinoma Treatment and Prognosis (35 papers) and Liver Disease Diagnosis and Treatment (26 papers). David O. Cosgrove is often cited by papers focused on Ultrasound and Hyperthermia Applications (67 papers), Hepatocellular Carcinoma Treatment and Prognosis (35 papers) and Liver Disease Diagnosis and Treatment (26 papers). David O. Cosgrove collaborates with scholars based in United Kingdom, United States and Germany. David O. Cosgrove's co-authors include Martin Blomley, Robert J. Eckersley, Jeffrey C. Bamber, R P Kedar, Adrian Lim, Chris Harvey, Caroline J Doré, Vito Cantisani, Paul S. Sidhu and Nayna Patel and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Radiology.

In The Last Decade

David O. Cosgrove

190 papers receiving 9.7k citations

Hit Papers

EFSUMB Guidelines and Rec... 2012 2026 2016 2021 2017 2012 2021 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David O. Cosgrove United Kingdom 51 3.8k 3.6k 2.0k 1.9k 1.5k 193 10.0k
Ji‐Bin Liu United States 51 2.0k 0.5× 3.1k 0.9× 1.1k 0.5× 1.1k 0.6× 1.9k 1.3× 320 9.1k
Fred T. Lee United States 53 2.7k 0.7× 3.2k 0.9× 4.2k 2.0× 1.8k 1.0× 2.3k 1.5× 206 11.2k
Peter N. Burns Canada 59 4.3k 1.1× 5.7k 1.6× 2.5k 1.2× 1.7k 0.9× 1.3k 0.9× 194 10.1k
Nathalie Lassau France 43 2.0k 0.5× 1.7k 0.5× 1.3k 0.6× 879 0.5× 1.2k 0.8× 171 7.0k
Stephen B. Solomon United States 57 2.9k 0.8× 1.9k 0.5× 2.7k 1.3× 726 0.4× 2.1k 1.4× 369 11.3k
Damian E. Dupuy United States 51 2.0k 0.5× 2.9k 0.8× 3.6k 1.7× 1.2k 0.6× 3.6k 2.4× 193 13.1k
Theo J. M. Ruers Netherlands 50 2.4k 0.6× 1.6k 0.4× 2.5k 1.2× 650 0.3× 1.7k 1.1× 241 8.7k
Elmar M. Merkle United States 47 3.7k 1.0× 917 0.3× 1.5k 0.7× 1.5k 0.8× 2.3k 1.5× 221 7.9k
Stephanie R. Wilson Canada 54 2.4k 0.6× 2.0k 0.6× 3.4k 1.7× 3.4k 1.8× 2.9k 1.9× 186 9.2k
Carlo Bartolozzi Italy 54 2.5k 0.7× 1.1k 0.3× 5.4k 2.6× 3.2k 1.7× 2.4k 1.6× 336 11.0k

Countries citing papers authored by David O. Cosgrove

Since Specialization
Citations

This map shows the geographic impact of David O. Cosgrove's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David O. Cosgrove with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David O. Cosgrove more than expected).

Fields of papers citing papers by David O. Cosgrove

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David O. Cosgrove. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David O. Cosgrove. The network helps show where David O. Cosgrove may publish in the future.

Co-authorship network of co-authors of David O. Cosgrove

This figure shows the co-authorship network connecting the top 25 collaborators of David O. Cosgrove. A scholar is included among the top collaborators of David O. Cosgrove based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David O. Cosgrove. David O. Cosgrove is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klein, Eric A., Donald Richards, Allen Lee Cohn, et al.. (2021). Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Annals of Oncology. 32(9). 1167–1177. 520 indexed citations breakdown →
2.
Knox, Jennifer J., Mairéad G. McNamara, Lipika Goyal, et al.. (2020). 80TiP Global phase III study of NUC-1031 plus cisplatin vs gemcitabine plus cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121). Annals of Oncology. 31. S272–S273. 2 indexed citations
3.
Lim, Adrian, et al.. (2017). Microflow imaging: New Doppler technology to detect low-grade inflammation in patients with arthritis. European Radiology. 28(3). 1046–1053. 53 indexed citations
4.
Eckersley, Robert J., et al.. (2015). Correction of Non-Linear Propagation Artifact in Contrast-Enhanced Ultrasound Imaging of Carotid Arteries: Methods and in Vitro Evaluation. Ultrasound in Medicine & Biology. 41(7). 1938–1947. 13 indexed citations
5.
Harvey, Chris, Ali Alsafi, An Ngo, et al.. (2015). Role of US Contrast Agents in the Assessment of Indeterminate Solid and Cystic Lesions in Native and Transplant Kidneys. Radiographics. 35(5). 1419–1430. 60 indexed citations
6.
Harvey, Chris, et al.. (2014). Ultrasound of the gall bladder and biliary tree: part 2. British Journal of Hospital Medicine. 75(6). 318–324. 1 indexed citations
7.
Harvey, Chris, et al.. (2014). Characterizing benign liver lesions and trauma with contrast-enhanced ultrasound. British Journal of Hospital Medicine. 75(2). 91–95. 6 indexed citations
8.
Harvey, Chris, et al.. (2014). Characterizing malignant liver lesions with contrast-enhanced ultrasound. British Journal of Hospital Medicine. 75(3). 151–154. 4 indexed citations
9.
Harvey, Chris, et al.. (2014). Ultrasound of the gall bladder and biliary tree: part 1. British Journal of Hospital Medicine. 75(6). 312–317. 3 indexed citations
10.
Lim, Adrian, et al.. (2008). Ultrasound in breast imaging. British Journal of Hospital Medicine. 69(Sup1). M6–M9. 4 indexed citations
11.
Liang, Haidong, et al.. (2005). Pluronic block copolymers:a novel function in ultrasound-mediated gene transfer. Zhonghua chaosheng yingxiangxue zazhi. 14(11). 858–862. 1 indexed citations
12.
Albrecht, Thomas, Martin Blomley, Peter N. Burns, et al.. (2003). Improved Detection of Hepatic Metastases with Pulse-Inversion US during the Liver-specific Phase of SHU 508A: Multicenter Study. Radiology. 227(2). 361–370. 175 indexed citations
13.
Okada, Masahiro, Thomas Albrecht, Martin Blomley, et al.. (2002). Heterogeneous delayed enhancement of the liver after ultrasound contrast agent injection—a normal variant. Ultrasound in Medicine & Biology. 28(8). 1089–1092. 7 indexed citations
14.
Bamber, Jeffrey C., Paul E. Barbone, Nigel L. Bush, et al.. (2002). Progress in Freehand Elastography of the Breast. IEICE Transactions on Information and Systems. 85(1). 5–14. 29 indexed citations
15.
Dewbury, K. C., Hylton B. Meire, David O. Cosgrove, & P. Farrant. (2001). Ultrasound in obstetrics and gynaecology. Churchill Livingstone eBooks. 16 indexed citations
16.
Bamber, Jeffrey C., Robert J. Eckersley, & David O. Cosgrove. (1994). 3-D reconstruction of combined colour Doppler and grey scale images of breast tumours. Ultrasound in Medicine & Biology. 1 indexed citations
17.
Cosgrove, David O., Hylton B. Meire, & K. C. Dewbury. (1993). Abdominal and general ultrasound. Churchill Livingstone eBooks. 92 indexed citations
18.
Kedar, R P & David O. Cosgrove. (1993). Echo‐poor periportal cuffing: Ultrasonographic appearance and significance. Journal of Clinical Ultrasound. 21(7). 464–467. 9 indexed citations
19.
Cosgrove, David O., et al.. (1983). Ultrasound in inflammatory disease. Churchill Livingstone eBooks. 3 indexed citations
20.
Hill, Christopher, V. R. McCready, & David O. Cosgrove. (1978). Ultrasound in tumour diagnosis. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026